Listed

Moderna, Inc.

MRNANasdaqCIK 1682852HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$145.0m, Q2 FY2026
Operating income−$815.0m, Q2 FY2026
Net income−$782.0m, Q2 FY2026
Moderna, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m1,831Revenue, Q3 FY2023, three months to 2023-09-30$1.83bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0001682852-24-000060.Report this figure2,811Revenue, Q4 FY2023, three months to 2023-12-31$2.81bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure167Revenue, Q1 FY2024, three months to 2024-03-31$167.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-01, accession 0001682852-25-000034.Report this figure241Revenue, Q2 FY2024, three months to 2024-06-30$241.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-01, accession 0001682852-25-000044.Report this figure1,862Revenue, Q3 FY2024, three months to 2024-09-30$1.86bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure966Revenue, Q4 FY2024, three months to 2024-12-31$966.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure108Revenue, Q1 FY2025, three months to 2025-03-31$108.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure142Revenue, Q2 FY2025, three months to 2025-06-30$142.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure1,016Revenue, Q3 FY2025, three months to 2025-09-30$1.02bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure678Revenue, Q4 FY2025, three months to 2025-12-31$678.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure389Revenue, Q1 FY2026, three months to 2026-03-31$389.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure145Revenue, Q2 FY2026, three months to 2026-06-30$145.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure
Cost of revenue$m2,241Cost of revenue, Q3 FY2023, three months to 2023-09-30$2.24bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-07, accession 0001682852-24-000060.Report this figure929Cost of revenue, Q4 FY2023, three months to 2023-12-31$929.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure96.0Cost of revenue, Q1 FY2024, three months to 2024-03-31$96.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-01, accession 0001682852-25-000034.Report this figure115Cost of revenue, Q2 FY2024, three months to 2024-06-30$115.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-01, accession 0001682852-25-000044.Report this figure514Cost of revenue, Q3 FY2024, three months to 2024-09-30$514.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure739Cost of revenue, Q4 FY2024, three months to 2024-12-31$739.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure90.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$90.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure119Cost of revenue, Q2 FY2025, three months to 2025-06-30$119.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure207Cost of revenue, Q3 FY2025, three months to 2025-09-30$207.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure452Cost of revenue, Q4 FY2025, three months to 2025-12-31$452.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure955Cost of revenue, Q1 FY2026, three months to 2026-03-31$955.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure93.0Cost of revenue, Q2 FY2026, three months to 2026-06-30$93.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure
Research and development$m1,160Research and development, Q3 FY2023, three months to 2023-09-30$1.16bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001682852-24-000060.Report this figure1,406Research and development, Q4 FY2023, three months to 2023-12-31$1.41bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure1,063Research and development, Q1 FY2024, three months to 2024-03-31$1.06bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-01, accession 0001682852-25-000034.Report this figure1,221Research and development, Q2 FY2024, three months to 2024-06-30$1.22bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-01, accession 0001682852-25-000044.Report this figure1,137Research and development, Q3 FY2024, three months to 2024-09-30$1.14bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure1,122Research and development, Q4 FY2024, three months to 2024-12-31$1.12bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure856Research and development, Q1 FY2025, three months to 2025-03-31$856.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure700Research and development, Q2 FY2025, three months to 2025-06-30$700.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure801Research and development, Q3 FY2025, three months to 2025-09-30$801.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure775Research and development, Q4 FY2025, three months to 2025-12-31$775.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure649Research and development, Q1 FY2026, three months to 2026-03-31$649.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure651Research and development, Q2 FY2026, three months to 2026-06-30$651.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure
Operating income$m(2,012)Operating income, Q3 FY2023, three months to 2023-09-30−$2.01bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001682852-24-000060.Report this figure6.0Operating income, Q4 FY2023, three months to 2023-12-31$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure(1,266)Operating income, Q1 FY2024, three months to 2024-03-31−$1.27bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-01, accession 0001682852-25-000034.Report this figure(1,363)Operating income, Q2 FY2024, three months to 2024-06-30−$1.36bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-01, accession 0001682852-25-000044.Report this figure(70.0)Operating income, Q3 FY2024, three months to 2024-09-30−$70.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure(1,246)Operating income, Q4 FY2024, three months to 2024-12-31−$1.25bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure(1,050)Operating income, Q1 FY2025, three months to 2025-03-31−$1.05bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure(907)Operating income, Q2 FY2025, three months to 2025-06-30−$907.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure(260)Operating income, Q3 FY2025, three months to 2025-09-30−$260.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure(857)Operating income, Q4 FY2025, three months to 2025-12-31−$857.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure(1,388)Operating income, Q1 FY2026, three months to 2026-03-31−$1.39bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure(815)Operating income, Q2 FY2026, three months to 2026-06-30−$815.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure
Income tax$m1,672Income tax, Q3 FY2023, three months to 2023-09-30$1.67bn. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0001682852-24-000060.Report this figure(147)Income tax, Q4 FY2023, three months to 2023-12-31−$147.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure10.0Income tax, Q1 FY2024, three months to 2024-03-31$10.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-01, accession 0001682852-25-000034.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-01, accession 0001682852-25-000044.Report this figure8.0Income tax, Q3 FY2024, three months to 2024-09-30$8.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure(64.0)Income tax, Q4 FY2024, three months to 2024-12-31−$64.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure7.0Income tax, Q1 FY2025, three months to 2025-03-31$7.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure7.0Income tax, Q2 FY2025, three months to 2025-06-30$7.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure13.0Income tax, Q3 FY2025, three months to 2025-09-30$13.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure27.0Income tax, Q4 FY2025, three months to 2025-12-31$27.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure9.0Income tax, Q1 FY2026, three months to 2026-03-31$9.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure15.0Income tax, Q2 FY2026, three months to 2026-06-30$15.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure
Net income$m(3,630)Net income, Q3 FY2023, three months to 2023-09-30−$3.63bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001682852-24-000060.Report this figure217Net income, Q4 FY2023, three months to 2023-12-31$217.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure(1,175)Net income, Q1 FY2024, three months to 2024-03-31−$1.18bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-01, accession 0001682852-25-000034.Report this figure(1,279)Net income, Q2 FY2024, three months to 2024-06-30−$1.28bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-01, accession 0001682852-25-000044.Report this figure13.0Net income, Q3 FY2024, three months to 2024-09-30$13.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure(1,120)Net income, Q4 FY2024, three months to 2024-12-31−$1.12bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure(971)Net income, Q1 FY2025, three months to 2025-03-31−$971.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure(825)Net income, Q2 FY2025, three months to 2025-06-30−$825.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure(200)Net income, Q3 FY2025, three months to 2025-09-30−$200.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure(826)Net income, Q4 FY2025, three months to 2025-12-31−$826.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure(1,343)Net income, Q1 FY2026, three months to 2026-03-31−$1.34bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure(782)Net income, Q2 FY2026, three months to 2026-06-30−$782.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure
Diluted EPS$ per share(9.53)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$9.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001682852-24-000060.Report this figurenot reported(3.07)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$3.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-01, accession 0001682852-25-000034.Report this figure(3.33)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$3.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-01, accession 0001682852-25-000044.Report this figure0.03Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figurenot reported(2.52)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$2.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure(2.13)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$2.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure(0.51)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figurenot reported(3.40)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$3.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure(1.97)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.97 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure
Basic EPS$ per share(9.53)Basic EPS, Q3 FY2023, three months to 2023-09-30−$9.53 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001682852-24-000060.Report this figurenot reported(3.07)Basic EPS, Q1 FY2024, three months to 2024-03-31−$3.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-01, accession 0001682852-25-000034.Report this figure(3.33)Basic EPS, Q2 FY2024, three months to 2024-06-30−$3.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-01, accession 0001682852-25-000044.Report this figure0.03Basic EPS, Q3 FY2024, three months to 2024-09-30$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figurenot reported(2.52)Basic EPS, Q1 FY2025, three months to 2025-03-31−$2.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure(2.13)Basic EPS, Q2 FY2025, three months to 2025-06-30−$2.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure(0.51)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figurenot reported(3.40)Basic EPS, Q1 FY2026, three months to 2026-03-31−$3.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure(1.97)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.97 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure

Balance sheet

Cash and equivalents$1.72bn, Q2 FY2026
Long-term debt$591.0m, Q2 FY2026
Shareholders' equity$6.76bn, Q2 FY2026
Moderna, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$bn2.9Cash and equivalents, Q3 FY2023, at 2023-09-30$2.93bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001682852-24-000060.Report this figure2.9Cash and equivalents, FY2023, at 2023-12-31$2.91bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-20, accession 0001682852-26-000033.Report this figure2.1Cash and equivalents, Q1 FY2024, at 2024-03-31$2.05bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-01, accession 0001682852-25-000034.Report this figure2.5Cash and equivalents, Q2 FY2024, at 2024-06-30$2.48bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-01, accession 0001682852-25-000044.Report this figure1.6Cash and equivalents, Q3 FY2024, at 2024-09-30$1.64bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure1.9Cash and equivalents, FY2024, at 2024-12-31$1.93bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-20, accession 0001682852-26-000033.Report this figure1.6Cash and equivalents, Q1 FY2025, at 2025-03-31$1.62bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure1.3Cash and equivalents, Q2 FY2025, at 2025-06-30$1.28bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure1.1Cash and equivalents, Q3 FY2025, at 2025-09-30$1.13bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure2.6Cash and equivalents, FY2025, at 2025-12-31$2.60bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure1.9Cash and equivalents, Q1 FY2026, at 2026-03-31$1.91bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure1.7Cash and equivalents, Q2 FY2026, at 2026-06-30$1.72bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure
Current assets$bn10.8Current assets, Q3 FY2023, at 2023-09-30$10.80bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-03, accession 0001682852-23-000042.Report this figure10.3Current assets, FY2023, at 2023-12-31$10.32bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-21, accession 0001682852-25-000022.Report this figure9.6Current assets, Q1 FY2024, at 2024-03-31$9.60bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-02, accession 0001682852-24-000027.Report this figure9.7Current assets, Q2 FY2024, at 2024-06-30$9.66bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-01, accession 0001682852-24-000046.Report this figure9.7Current assets, Q3 FY2024, at 2024-09-30$9.67bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001682852-24-000060.Report this figure8.1Current assets, FY2024, at 2024-12-31$8.10bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-20, accession 0001682852-26-000033.Report this figure6.8Current assets, Q1 FY2025, at 2025-03-31$6.77bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-01, accession 0001682852-25-000034.Report this figure6.2Current assets, Q2 FY2025, at 2025-06-30$6.17bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-01, accession 0001682852-25-000044.Report this figure6.6Current assets, Q3 FY2025, at 2025-09-30$6.60bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure6.5Current assets, FY2025, at 2025-12-31$6.54bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure5.8Current assets, Q1 FY2026, at 2026-03-31$5.77bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure5.8Current assets, Q2 FY2026, at 2026-06-30$5.82bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure
Total assets$bn19.5Total assets, Q3 FY2023, at 2023-09-30$19.45bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-03, accession 0001682852-23-000042.Report this figure18.4Total assets, FY2023, at 2023-12-31$18.43bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-21, accession 0001682852-25-000022.Report this figure16.7Total assets, Q1 FY2024, at 2024-03-31$16.73bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-02, accession 0001682852-24-000027.Report this figure15.7Total assets, Q2 FY2024, at 2024-06-30$15.68bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-01, accession 0001682852-24-000046.Report this figure15.8Total assets, Q3 FY2024, at 2024-09-30$15.80bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001682852-24-000060.Report this figure14.1Total assets, FY2024, at 2024-12-31$14.14bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-20, accession 0001682852-26-000033.Report this figure12.7Total assets, Q1 FY2025, at 2025-03-31$12.70bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-01, accession 0001682852-25-000034.Report this figure12.0Total assets, Q2 FY2025, at 2025-06-30$12.01bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-01, accession 0001682852-25-000044.Report this figure12.1Total assets, Q3 FY2025, at 2025-09-30$12.13bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure12.3Total assets, FY2025, at 2025-12-31$12.34bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure11.5Total assets, Q1 FY2026, at 2026-03-31$11.49bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure11.0Total assets, Q2 FY2026, at 2026-06-30$10.96bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure
Current liabilities$bn4.4Current liabilities, Q3 FY2023, at 2023-09-30$4.38bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-03, accession 0001682852-23-000042.Report this figure3.0Current liabilities, FY2023, at 2023-12-31$3.02bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-21, accession 0001682852-25-000022.Report this figure2.4Current liabilities, Q1 FY2024, at 2024-03-31$2.38bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-02, accession 0001682852-24-000027.Report this figure2.4Current liabilities, Q2 FY2024, at 2024-06-30$2.36bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-01, accession 0001682852-24-000046.Report this figure2.2Current liabilities, Q3 FY2024, at 2024-09-30$2.20bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001682852-24-000060.Report this figure2.2Current liabilities, FY2024, at 2024-12-31$2.21bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-20, accession 0001682852-26-000033.Report this figure1.6Current liabilities, Q1 FY2025, at 2025-03-31$1.60bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-01, accession 0001682852-25-000034.Report this figure1.6Current liabilities, Q2 FY2025, at 2025-06-30$1.57bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-01, accession 0001682852-25-000044.Report this figure1.7Current liabilities, Q3 FY2025, at 2025-09-30$1.68bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure2.0Current liabilities, FY2025, at 2025-12-31$1.99bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure2.4Current liabilities, Q1 FY2026, at 2026-03-31$2.40bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure2.5Current liabilities, Q2 FY2026, at 2026-06-30$2.53bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure
Total liabilities$bn6.0Total liabilities, Q3 FY2023, at 2023-09-30$6.00bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-03, accession 0001682852-23-000042.Report this figure4.6Total liabilities, FY2023, at 2023-12-31$4.57bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-21, accession 0001682852-25-000022.Report this figure3.9Total liabilities, Q1 FY2024, at 2024-03-31$3.91bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-02, accession 0001682852-24-000027.Report this figure4.0Total liabilities, Q2 FY2024, at 2024-06-30$3.97bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-01, accession 0001682852-24-000046.Report this figure3.9Total liabilities, Q3 FY2024, at 2024-09-30$3.88bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001682852-24-000060.Report this figure3.2Total liabilities, FY2024, at 2024-12-31$3.24bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-20, accession 0001682852-26-000033.Report this figure2.6Total liabilities, Q1 FY2025, at 2025-03-31$2.64bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-01, accession 0001682852-25-000034.Report this figure2.6Total liabilities, Q2 FY2025, at 2025-06-30$2.61bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-01, accession 0001682852-25-000044.Report this figure2.8Total liabilities, Q3 FY2025, at 2025-09-30$2.81bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure3.7Total liabilities, FY2025, at 2025-12-31$3.69bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure4.1Total liabilities, Q1 FY2026, at 2026-03-31$4.08bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure4.2Total liabilities, Q2 FY2026, at 2026-06-30$4.20bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure
Long-term debt$bnnot reportednot reportednot reportednot reportednot reported0.0Long-term debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-20, accession 0001682852-26-000033.Report this figurenot reportednot reportednot reported0.6Long-term debt, FY2025, at 2025-12-31$590.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure0.6Long-term debt, Q1 FY2026, at 2026-03-31$590.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure0.6Long-term debt, Q2 FY2026, at 2026-06-30$591.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure
Shareholders' equity$bn13.5Shareholders' equity, Q3 FY2023, at 2023-09-30$13.46bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001682852-24-000060.Report this figure13.9Shareholders' equity, FY2023, at 2023-12-31$13.85bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-20, accession 0001682852-26-000033.Report this figure12.8Shareholders' equity, Q1 FY2024, at 2024-03-31$12.82bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-01, accession 0001682852-25-000044.Report this figure11.7Shareholders' equity, Q2 FY2024, at 2024-06-30$11.71bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure11.9Shareholders' equity, Q3 FY2024, at 2024-09-30$11.93bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure10.9Shareholders' equity, FY2024, at 2024-12-31$10.90bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure10.1Shareholders' equity, Q1 FY2025, at 2025-03-31$10.07bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure9.4Shareholders' equity, Q2 FY2025, at 2025-06-30$9.40bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure9.3Shareholders' equity, Q3 FY2025, at 2025-09-30$9.33bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure8.7Shareholders' equity, FY2025, at 2025-12-31$8.65bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure7.4Shareholders' equity, Q1 FY2026, at 2026-03-31$7.41bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure6.8Shareholders' equity, Q2 FY2026, at 2026-06-30$6.76bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure

Cash flow

Operating cash flow−$526.0m, Q2 FY2026
Capital expenditure$37.0m, Q2 FY2026
Share repurchases$0, Q4 FY2024
Moderna, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(1,600)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$1.60bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001682852-24-000060. Derived: 9-month figure less the 6-month figure.Report this figure622Operating cash flow, Q4 FY2023, three months to 2023-12-31$622.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure(989)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$989.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0001682852-25-000034.Report this figure(1,274)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$1.27bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-01, accession 0001682852-25-000044. Derived: 6-month figure less the 3-month figure.Report this figure(1,566)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$1.57bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001682852-25-000075. Derived: 9-month figure less the 6-month figure.Report this figure825Operating cash flow, Q4 FY2024, three months to 2024-12-31$825.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure(1,037)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$1.04bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure(919)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$919.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0001682852-26-000150. Derived: 6-month figure less the 3-month figure.Report this figure(847)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$847.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001682852-25-000075. Derived: 9-month figure less the 6-month figure.Report this figure930Operating cash flow, Q4 FY2025, three months to 2025-12-31$930.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure(630)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$630.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure(526)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$526.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0001682852-26-000150. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m140Capital expenditure, Q3 FY2023, three months to 2023-09-30$140.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001682852-24-000060. Derived: 9-month figure less the 6-month figure.Report this figure220Capital expenditure, Q4 FY2023, three months to 2023-12-31$220.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure196Capital expenditure, Q1 FY2024, three months to 2024-03-31$196.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-01, accession 0001682852-25-000034.Report this figure182Capital expenditure, Q2 FY2024, three months to 2024-06-30$182.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-01, accession 0001682852-25-000044. Derived: 6-month figure less the 3-month figure.Report this figure151Capital expenditure, Q3 FY2024, three months to 2024-09-30$151.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001682852-25-000075. Derived: 9-month figure less the 6-month figure.Report this figure522Capital expenditure, Q4 FY2024, three months to 2024-12-31$522.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure117Capital expenditure, Q1 FY2025, three months to 2025-03-31$117.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure3.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$3.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-31, accession 0001682852-26-000150. Derived: 6-month figure less the 3-month figure.Report this figure33.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$33.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001682852-25-000075. Derived: 9-month figure less the 6-month figure.Report this figure39.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$39.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure62.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$62.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure37.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$37.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-31, accession 0001682852-26-000150. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m(1.0)Share repurchases, Q3 FY2023, three months to 2023-09-30−$1.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-07, accession 0001682852-24-000060. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-05-02, accession 0001682852-24-000027.Report this figure0.0Share repurchases, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-08-01, accession 0001682852-24-000046. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-07, accession 0001682852-24-000060. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-20, accession 0001682852-26-000033. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)398.00m, Q2 FY2026
Moderna, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares412Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30412,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-03, accession 0001682852-23-000042.Report this figure405Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31405,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-02, accession 0001682852-24-000027.Report this figure381Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30381,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-01, accession 0001682852-24-000046.Report this figure381Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30381,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001682852-24-000060.Report this figure382Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31382,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-01, accession 0001682852-25-000034.Report this figure384Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30384,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-01, accession 0001682852-25-000044.Report this figure399Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30399,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure386Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31386,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure388Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30388,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure390Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30390,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001682852-25-000075.Report this figure395Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31395,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-01, accession 0001682852-26-000060.Report this figure398Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30398,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure

Shares outstanding: 399.24mShares outstanding, period not labelled, at 2026-07-24399,235,889 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-07-31, accession 0001682852-26-000150.Report this figure at Jul 24, 2026, from the cover of the 10-Q filed Jul 31, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.